Back to search

Article

Improved Personalized Survival Prediction of Patients With Diffuse Large B-cell Lymphoma Using Gene Expression Profiling

2020-07-10

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>30-40% of patients with Diffuse Large B-cell Lymphoma (DLBCL) have an adverse clinical evolution. The increased understanding of DLBCL biology has shed light on the clinical evolution of this pathology, leading to the discovery of prognostic factors based on gene expression data, genomic rearrangements and mutational subgroups. Nevertheless, additional efforts are...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
be0fd6d9-815a-5f18-8e23-8e97f403c88b
DOI
10.21203/rs.3.rs-40793/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Improved Personalized Survival Prediction of Patients With Diffuse Large B-cell Lymphoma Using Gene Expression ProfilingDOI 10.21203/rs.3.rs-40793/v1
Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profilingSemantic proximity
Large-scale transcriptome data analysis reveals prognostic signature genes for overall survival prediction in diffuse large B cell lymphomaSemantic proximity
Prediction of Overall Survival Status of Diffuse Large B-Cell Lymphoma Using a Prognostic Classification ModelSemantic proximity
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosisSemantic proximity
Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell LymphomaSemantic proximity
A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell LymphomaSemantic proximity
Predictive biomarkers and molecular subtypes in DLBCL: insights from PCD gene expression and machine learningSemantic proximity
Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysisSemantic proximity
Next-generation prognostic assessment for diffuse large B-cell lymphoma.Semantic proximity
LymphGen-Sig: Integrating genetic and transcriptional states to predict therapeutic response in DLBCLSemantic proximity
Incremental value in outcome prediction with gene expression–based signatures in diffuse large B-cell lymphomaSemantic proximity
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCLSemantic proximity
Select a neighboring publication to make it the new centre.